COMPARISON OF NONSPECIFIC RADIOIMMUNOASSAY, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, AND FLUORESCENCE POLARIZATION IMMUNOASSAY FOR CYCLOSPORINE MONITORING IN RENAL-TRANSPLANTATION

被引：8
|
作者：
LEE, SF
YANG, WC
SHANN, TY
LUI, WY
WANG, RB
机构：
[1] VET GEN HOSP TAIPEI,DIV NEPHROL,TAIPEI 11217,TAIWAN
[2] VET GEN HOSP TAIPEI,DEPT GEN SURG,TAIPEI 11217,TAIWAN
来源：
THERAPEUTIC DRUG MONITORING | 1991年 / 13卷 / 02期
关键词：
CYCLOSPORINE; RADIOIMMUNOASSAY; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; FLUORESCENCE POLARIZATION IMMUNOASSAY;
D O I：
10.1097/00007691-199103000-00011
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Three methods, i.e., nonspecific radioimmunoassay (RIA; Incstar), fluorescence polarization immunoassay (FPIA; TDx Abbott), and high-performance liquid chromatography (HPLC), have been used for monitoring cyclosporine blood levels in renal transplantation patients. The levels obtained from 135 samples showed a modest correlation between RIA and HPLC, FPIA and HPLC, RIA and FRIA. The mean ratios of RIA to HPLC, FPIA to HPLC, and RIA to FPIA were 2.96, 4.14, and 0.73. The significant variations in cyclosporine levels result from the cross-reaction of antibody with some cyclosporine metabolites, by which these two methods often overestimate the true blood cyclosporine level. HPLC is a more effective and reliable method for pharmacokinetic studies and blood level monitoring of cyclosporine in clinical practice.
引用
收藏
页码：152 / 156
页数：5
相关论文
共 50 条
  • [1] COMPARISON OF ABBOTT TDX FLUORESCENCE POLARIZATION IMMUNOASSAY, SANDOZ RADIOIMMUNOASSAY, AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY METHODS FOR THE ASSAY OF SERUM CYCLOSPORINE
    SCHROEDER, TJ
    PESCE, AJ
    HASSAN, FM
    WERMELING, JR
    WARNER, A
    SCHLUETER, KT
    FIRST, MR
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (02) : 345 - 347
  • [2] COMPARISON OF A NONINSTRUMENTED IMMUNOASSAY FOR CARBAMAZEPINE TO HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND FLUORESCENCE POLARIZATION IMMUNOASSAY
    COCHRAN, EB
    MASSEY, KL
    PHELPS, SJ
    CRAMER, JA
    TOFTNESS, BR
    DENIO, LS
    DRAKE, ME
    EPILEPSIA, 1990, 31 (04) : 480 - 484
  • [3] COMPARATIVE ANALYSES OF CYCLOSPORINE IN WHOLE-BLOOD AND PLASMA BY RADIOIMMUNOASSAY, FLUORESCENCE POLARIZATION IMMUNOASSAY, AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    LINDHOLM, A
    HENRICSSON, S
    THERAPEUTIC DRUG MONITORING, 1990, 12 (04) : 344 - 352
  • [4] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOR CYCLOSPORINE MEASUREMENT - COMPARISON WITH RADIOIMMUNOASSAY
    PLEBANI, M
    MASIERO, M
    PALEARI, CD
    SCIACOVELLI, L
    FAGGIAN, D
    BURLINA, A
    JOURNAL OF CHROMATOGRAPHY, 1989, 476 : 93 - 98
  • [5] TOTAL AND FREE QUINIDINE BY FLUORESCENCE POLARIZATION IMMUNOASSAY AND COMPARISON WITH HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    CHEN, BH
    TAYLOR, EH
    KENNEDY, E
    ACKERMAN, B
    OLSEN, K
    PAPPAS, AA
    CLINICA CHIMICA ACTA, 1988, 175 (01) : 107 - 108
  • [6] THERAPEUTIC DRUG-MONITORING OF FLECAINIDE USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND COMPARISON WITH FLUORESCENCE POLARIZATION IMMUNOASSAY
    WOOLLARD, GA
    JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 487 (02): : 409 - 419
  • [7] MONITORING OF CYCLOSPORINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    SEWING, KP
    CHRISTIANS, U
    BLECK, JS
    STROHMEYER, S
    BEIL, W
    KOHLHAW, K
    WONIGEIT, K
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 113 (08) : 311 - 314
  • [8] ANALYTICAL METHODOLOGIES FOR CYCLOSPORINE PHARMACOKINETICS - A COMPARISON OF RADIOIMMUNOASSAY WITH HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    BUICE, RG
    STENTZ, FB
    GURLEY, BJ
    JOURNAL OF LIQUID CHROMATOGRAPHY, 1987, 10 (2-3): : 421 - 438
  • [9] COMPARISON OF DIGOXIN ANALYSIS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY POSTCOLUMN DERIVATIZATION AND FLUORESCENCE POLARIZATION IMMUNOASSAY
    EMBREE, L
    MCERLANE, KM
    XENOBIOTICA, 1990, 20 (06) : 635 - 643
  • [10] COMPARISON OF A NEW HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY METHOD WITH FLUORESCENCE POLARIZATION IMMUNOASSAY FOR ANALYSIS OF METHOTREXATE
    NAJJAR, TAO
    MATAR, KM
    ALFAWAZ, IM
    THERAPEUTIC DRUG MONITORING, 1992, 14 (02) : 142 - 146
12345